Project: Biomarker Guided Prostate Cancer Management

Acronym BioGuidePCa (Reference Number: 11023)
Duration 01/07/2017
Project Topic The BioGuidePCa project is designed to address the European Market demand for a diagnostic test which enables distinguishing between insignificant and significant prostate cancer (PCa). The proposed test detects peptides indicative of PCa by capillary electrophoresis-mass spectrometry (CE-MS). The output of the project will be a non-invasive test, called the “PCa Status Test”, designed to guide the treatment decision-making for patients on active surveillance. This is not a clinical study.
Network Eurostars 2
Call Eurostars Cut-Off 6

Project partner

Number Name Role Country
1 Mosaiques Diagnostics GmbH Coordinator Germany
2 Medizinische Universität Innsbruck Partner Austria
3 Universitätsklinikum Schleswig-Holstein Partner Germany